S10 Ep27: FDA Approval Insights: Cilta-Cel in R/R Myeloma After at Least 1 Prior Line of Therapy
OncLive® On Air
00:00
Exploring the Safety and Role of Siltocel in Multiple Myeloma Treatment
Exploring the use of Siltocel in high-risk multiple myeloma patients, considering safety, efficacy, and potential benefits for early relapse situations.
Play episode from 06:36
Transcript
